Fatal cardiovascular risk in Poland as determined via Internet
More details
Hide details
Medical Unversity of Gdańsk, Poland
Ann Agric Environ Med 2017;24(2):176–180
Web information systems can serve as a diagnostic tool for Internet users and to support the epidemiological work of doctors and health care providers. As part of this work, a system for detecting and calculating cardiovascular risk has been created.

1) Application of web-based risk assessment of cardiovascular death; 2) an attempt to evaluate the distribution of selected risk factors among the population of Polish Internet users; 3) implementation of the epidemiological imaging system of cardiovascular risk factors.

Material and Methods:
The ‘Ryzyko’ programme ( available on the Internet. To assess cardiovascular death risk in a ten year period the algorithm of the SCORE project was used. 28,320 solutions of the algorithm have been registered.

Over 28,000 webpage visitors entered the required data and received the outcome. More than 71% of Internauts who entered the data received the recommendation for medical control. The result of the programme is a graphic presentation of the distribution of the calculated risk of death, based on previously gathered information given by the Internauts in particular provinces in Poland.

Automatic monitoring of the incidence of cardiovascular risk factors in Poland provides information for epidemiological studies. The system meets the characteristics of diagnostic programmes that can assist epidemiologic-based and therapeutic decisions.

Bartosz Trzeciak   
Medical Unversity of Gdańsk, Poland
1. World Health Organization Regional Office for Europe, Copenhagen, 2010. European Health for All database (HFA-DB).
2. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Version for 2007.
3. Główny Urząd Statystyczny (Central Statistical Office). Mały Rocznik Statystyczny Polski 2010. Zakład Wydawnictw Statystycznych, Warszawa 2010.
4. Eurostat, The Statistical Office of the European Union. Eurostat. Updated 2009.
5. European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Continued by representatives of nine societies and by invited experts). Eur J Cardiov Prev R. 2007; 4 (Suppl 2).
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezun A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 53 countries (the INTERHEART study): case-control study. Lancet. 2004; 11; 364(9438): 937–52.
7. Virtanen M, Ferrie JE, Singh-Manoux A, Shipley MJ, Vahtera J, Marmot MG, et al. Overtime work and incident coronary heart disease: the Whitehall II prospective cohort study. Eur Heart J. 2010; 31: 1737–44. Date of Electronic Publication: 2010 May 11.
8. Conroy RM, Pyorala K, Fitzerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24:987–1003.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC practice Guidelines for the Management of Arterial Hypertension. ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007; 25: 1751–1762.
10. Answer of Secretary of State in the Ministry of Infrastructure – the interpellation No. 2321 on access to the Internet in Poland.
11. Feldman RD, Campbell N, Larochelle P, Bolli P, Burgess ED, Carruthers SG, et al. 1999 Canadian recommendations for the management of hypertension. CMAJ. 1999; 161(Suppl 12): S1-S17.
12. Campbell NR, McAlister FA, Brant R, Levine M, Drouin D, Feldman R, et al. Canadian Hypertension Education Process and Evaluation Committee Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens. 2003; 21(8): 1591–1597.
13. Quinn RR, Hemmelgarn BR, Padwal RS, Myers MG, Cloutier L, Bolli P, et al. Canadian Hypertension Education Program. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I – blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2010; 26(5): 241–248.
14. Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, et al. Canadian Hypertension Education Program. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 – therapy. Can J Cardiol. 2010; 26(5): 249–258.
15. AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association. Circulation. 2009; 120: 1296–1336.
16. Babińska Z, Bandosz P, Nowicka-Sauer K, Trzeciak B, Pietrzykowska M, Gutknecht P, Siebert J. The cognizance of patient s own blood pressure values and the hypertension prevalence among rural population – „Kiełpino program”. Family Med Prim Care Rev. 2007; 9(3): 363–365.
17. Raport CBOS – korzystanie z Internetu. Warszawa, lipiec 2009 BS/96/2009.
18. The percentage of women and men use the Internet regularly by regular use of the Internet among men and women (EU countries). 1.10.2010.
19. Jóźwiak J, Mastej M, Lukas W, Kądziołka M, Orzechowski M. Lipido-gram 2003 – evaluation and comparison of lipidogram parameters and body mass index in relation with patients’ gender and age in population of South and West Poland. Part 1.: evaluation of body mass index (BMI) in relation with sex and age. Probl Med Rodz. 2005; 7: 27–32.
20. Mastej M, Jóźwiak J, Lukas W, Piwowarska W, Tykarski A, Orzechowski M. Evaluation and comparison of lipid parameters, depending on gender and body mass index (BMI). Kariol Pol. 2006; 64, 8 (Suppl 2): S153-S160.
21. Tendera M, Kozakiewicz K, Bartnik M, et al. The presence of major risk factors of coronary heart disease in a group of 41 927 people under the action of primary prevention in southern Poland (Poland Epidemiological Survey Southeren – SPES). Wiad Lek. 2001; 5: 293–303.
22. Pająk A, Wiercińska E, Polakowska M, Kozakiewicz K, Kaczmarczyk-Chałas K, Tykarski A, et al. Rozpowszechnienie dyslipidemii u mężczyzn i kobiet w wieku 20–74 lat w Polsce. Wyniki programu WOBASZ. Kardiol Pol. 2005; 63: 6 (Suppl 4): 2–6.
23. Zdrojewski T, Bandosz P, Szpakowski P, Konarski R, Jakubowski Z, Manikowski A, et al. The prevalence of major risk factors of the cardiovascular diseases in Poland. The results of NATPOL PLUS Study. Kardiol Pol. 2004; 61 (Suppl IV): 1–26.
24. Rywik S, Broda G, Piotrowski W, et al. Epidemiologia chorób układu krążenia. Program Pol-MONICA Warszawa. Kardiol Pol. 1996; 44 (Supl. II).
25. Pająk A, Kawalec E. Rozpowszechnienie i skuteczność postępowania w nadciśnieniu tętniczym. Wyniki badania długofalowego Pol-MONICA Kraków. Medipress Kardiologia. 1994; 1: 3–6.
26. Kawecka-Jaszcz K, Pościk-Urbańska A, Jankowski P. Rozpowszechnienie nadciśnienia tętniczego w zależności od płci w świetle badań epidemiologicznych w Polsce. Nadciśn Tętn. 2007; 11: 377–383.
27. Podolec P, Kopeć G. Rozpoznawanie palenia tytoniu wśród dorosłych Polaków – wyniki badania POLSCREEN. W: Cieśliński A, Pająk A, Podolec P, Rynkiewicz A. Ogólnopolski Program Prewencji Choroby Wieńcowej POLSCREEN. Termedia. Poznań, 2006. Wyd I. p. 69–81.